Skip to main content

Table 2 Health care services and medication utilization related to severity

From: Health care costs and resource utilization for different asthma severity stages in Colombia: a claims data analysis

 

Total

n = 20,410

Mild

intermittent

n = 14,191

Mild

Persistent

n = 3680

Moderate Persistent

n = 1408

Severe persistent

n = 1131

p-valuea

Medical services (n, %)b

 ED visits*

721 (3.5)

462 (12.5)

163 (11.5)

96 (8.5)

< 0.001

  Mean (SD)c

1.1 (0.5)

1 (0)

1.3 (0.5)

1.4 (1.1)

 

 Hospitalizations*

1137 (5.5)

495 (13.4)

278 (19.7)

364 (32.1)

< 0.001

  Mean (SD)c

1.6 (1.6)

1 (0)

1.5 (0.6)

2.5 (2.6)

 

 Specialized physician visits

5764 (28.2)

3539 (24.9)

1057 (28.7)

578 (41.0)

590 (52.1)

< 0.001

 General physician visits

11,685 (57.2)

8445 (59.5)

1761 (47.8)

755 (53.6)

724 (64.1)

< 0.001

 Other ambulatory services

1653 (8.1)

1009 (7.1)

297 (8.0)

160 (11.3)

187 (16.5)

< 0.001

Total frequency of any medical service

17,059 (83.5)

11,933 (84.1)

2923 (79.4)

1167 (82.8)

1036 (91.6)

0.026

Asthma medication prescriptions (n, %)b

 Controller medications

  ICS

4841 (23.7)

1777 (12.5)

1410 (38.3)

821 (58.3)

833 (73.6)

< 0.001

  ICS + LABA

487 (2.4)

32 (0.2)

88 (2.4)

171 (12.1)

196 (17.3)

< 0.001

  LABA

188 (0.9)

18 (0.1)

65 (1.7)

38 (2.7)

67 (5.9)

< 0.001

  LM

660 (3.2)

0 (0)

221 (6.0)

154 (10.9)

285 (25.2)

< 0.001

  Theophylline

240 (1.1)

36 (0.2)

62 (1.6)

63 (4.4)

79 (6.9)

< 0.001

 Rescue Medications

  Oral corticosteroids

4594 (22.5)

399 (2.8)

2236 (60.7)

998 (70.8)

961 (84.9)

< 0.001

  SABA

4911 (24.0)

1242 (8.7)

1798 (48.8)

946 (67.2)

925 (81.8)

< 0.001

Total frequency of any medication

9509 (46.6)

3880 (27.3)

3183 (86.5)

1336 (94.9)

1110 (98.1)

< 0.001

  1. *For ED visits and hospitalizations trend analysis was conducted for mild to severe persistent categories
  2. aCochran-Armitage test. P for trend is reported
  3. bThe number of patients using each medical service is reported. Relative frequencies were calculated using the total number of subjects (N) for each column as denominator. Patients may have used more than one service in the cost analysis period
  4. cMean number of times that a patient required to use this medical service during the cost analysis period
  5. ED emergency department; ICS inhaled corticosteroids; ICS + LABA inhaled corticosteroids-long acting B2 agonist combination; LABA long acting B2 agonist; LM leukotriene modifiers; SABA short acting B2 agonist